Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 115.09MWorking Capital
VS
Market
Sector
Industry
History
$ 11.25Close
$ 8.84 - $ 12.53 52-Week Range
Ticker Information
Ticker
BBOTCompany Name
BRIDGEBIO ONCOLOGY THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQBRIDGEBIO ONCOLOGY THERAPEUTICS INC - Working Capital Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BBOT - Working Capital Historical data
| Date | Current Assets | Current Liabilities | Working Capital |
|---|---|---|---|
| 6/30/2025 | $ 142.35M | $ 27.25M | $ 115.09M |
| 3/31/2025 | $ 1.24M | $ 1.87M | $ -631.35K |
| 12/31/2024 | $ 1.95M | $ 187.51K | $ 1.76M |
| 9/30/2024 | $ 2.04M | $ 126.69K | $ 1.92M |
| 6/30/2024 | $ 2.08M | $ 79.14K | $ 2M |
| 3/31/2024 | $ 2.11M | $ 23.33K | $ 2.09M |
| 12/31/2023 | $ 0 | $ 396.46K | $ 0 |
| 9/30/2023 | $ 0 | $ 166.46M | $ 0 |
Key Performance Insights, Last 5 Years
- BRIDGEBIO ONCOLOGY THERAPEUTICS INC's latest trailing twelve months (TTM) Working Capital stands at $ 0.
- Over the past 5 years, BRIDGEBIO ONCOLOGY THERAPEUTICS INC's average Working Capital has been $ 20.37M.
- The median Working Capital for BRIDGEBIO ONCOLOGY THERAPEUTICS INC during this period was $ 1.96M
- BRIDGEBIO ONCOLOGY THERAPEUTICS INC reached its highest Working Capital over the past 5 years at $ 115.09M.
- The lowest Working Capital recorded by BRIDGEBIO ONCOLOGY THERAPEUTICS INC in the same timeframe $ -631.35K
Similar metrics to Working Capital:
- Current Ratio - [Calculation] The current ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations due within one year. Calculated by dividing current assets [AssetsC] by current liabilities [LiabilitiesC].
- Quick Ratio - [Calculation] The quick ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations without the need to sell its inventory or receive additional financing. Calculated by dividing current assets [AssetsC] minus [Inventory] by current liabilities [LiabilitiesC].
- Current Liabilities - [Balance Sheet] The current (short-term) portion of [Liabilities] includes obligations that are due to be paid to creditors within one year, reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]
- Total Liabilities - [Balance Sheet] Total liabilities are the sum of all possible claims against the company. Common examples are [Debt], [Payables], deferred revenues, issued bonds, warranties, and tax liabilities.
- Non-Current Liabilities - [Balance Sheet] The non-current (long-term) portion of [Liabilities] includes obligations that are due to be paid to creditors more than year in the future, reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]
Definition of Working Capital
[Calculation] The working capital represents the capital used in day-to-day operations. It is the difference between a company’s short-term assets [AssetsC] and current liabilities [LiabilitiesC].AssetsC - LiabilitesC
(=) Working Capital Working Capital for BRIDGEBIO ONCOLOGY THERAPEUTICS INC is calculated as follows: AssetsC [ $ 0 ] - LiabilitesC [ $ 166.46M ]
(=) Working Capital [ $ 0 ] BBOT - Working Capital, Last 5 years
$ -631.35K
Minimum
Mar 31, 2025
$ 115.09M
Maximum
Jun 30, 2025
$ 20.37M
Average
$ 1.96M
Median
Working Capital Benchmark AnalysisMarket
The chart above depicts the distribution of Working Capital for companies in the Total Stock Market. The average Working Capital of the companies is $ 96.23M with a standard deviation of $ 173.95M.
The following table provides additional summary stats:
Working Capital in the Market:
| filtered constituents | 2.79K |
|---|---|
| min | $ -465.2M |
| max | $ 607.04M |
| average | $ 96.23M |
| median | $ 32.11M |
| std | $ 173.95M |